Early disease detection performing NMR (For Research Use Only)
Register to download slides & media
Standardized NMR can identify metabolites in a wide concentration range in body fluids. Highly efficient analysis software provided by Bruker can quantify a multitude of small molecules in urine and plasma/serum while delivering also lipoprotein subclass information in the latter in a fully automated approach
Prof. Luchinat will discuss the importance of targeted and nontargeted metabolomics NMR analysis in his research and highlight the impact of quantification information generated under standardized conditions on the Bruker IVDr platform. He will show the effect of being able to detect small molecules as well as lipoprotein information for the development of diagnostic tools e.g. in cardiovascular or cancer research.
Additionally, in this webinar Prof. Holmes, will highlight the reproducibility and transferability of NMR in a large ring test, compare quantification routines and their reliability and relevance to her research. She will also show examples using targeted and non-targeted analysis out of her research. The suitability of NMR for high throughput screening is discussed.
What to expect
In this webinar, viewers can expect a discussion into how new methods of determining the concentration and type of metabolites in plasma/serum and urine have distinct advantages over current conventional methods, and how this new method can be used as a large-scale screening technique. Viewers can also expect to see how metabolic research can use NMR as a leading analysis tool for body fluids.
The main points that viewers can take away from the webinar will
- The clinical translation of metabolomics research: metabolomics as a potential diagnostic tool for disease recognition and staging.
- How NMR can be used in high throughput metabolomics screening.
- The robustness of standardized NMR technology , especially with regard to reproducibility and transferability
Who should attend
The webinar will be of interest to people performing human metabolomics studies and clinical trials, clinicians, metabolomics researchers who work in industry, private organizations and academia, R&D professionals, healthcare professionals, food researchers, nutritionists, analytical service providers and NMR experts.